Delivery Order SPE2DR25D2206-SPE2DR26F9DE5
Award Date 11/25/25
Potential Completion Date 12/17/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count packages) under a firm fixed-price contract. The delivery order is scheduled for completion by September 18, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lorbrena 100 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $24.5K delivery order to AmerisourceBergen Drug Corp for 30 tablets of Lorbrena 100 mg on October 22, 2025, with completion scheduled for November 13, 2025. This firm fixed-price contract, issued without set-aside provisions, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs through competitive award procedures. This...
- The Defense Logistics Agency awarded a delivery order valued at $12.25K to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count) with a completion deadline of January 5, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Lorbrena 100 mg tablets (30-count units) with a ceiling value of $23,248.72. This firm fixed-price delivery order is scheduled for completion by July 16, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded transaction, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Lorbrena 100 mg tablets (30-count) valued at $11,624.35. This firm fixed-price delivery order, awarded on August 21, 2025, is scheduled for completion by September 12, 2025, with performance at the vendor's Conshohocken facility. The award represents a non-competitive, non-set-aside transaction, indicating it was...
- The Defense Logistics Agency awarded a $12.25K delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Lorbrena 100 mg tablets (30-count units) with delivery expected by December 8, 2025. This competitive award, which carries no set-aside designation, reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract represents a firm fixed-price delivery order executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,624.35 on October 29, 2025, for the supply of Lorbrena 100 mg tablets (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count units) with a firm fixed price structure and an ultimate completion date of October 14, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lorbrena 100mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $23,248.70, is scheduled for completion by August 11, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's...